Skip to Content
You are currently on the new version of our website. Access the old version .
SciSci
  • Review
  • Open Access

11 February 2026

16 Pages

Transdiagnostic Approaches to ADHD: A Narrative Review

and
Faculty of Humanities and Social Sciences, University of Split, 21000 Split, Croatia
*
Author to whom correspondence should be addressed.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that impair functioning across multiple situations. Despite extensive research on its clinical presentation, neurobiological substrates, genetic contributions, and environmental risk factors, ADHD remains a heterogeneous disorder with complex comorbidities. This narrative review synthesizes historical and contemporary transdiagnostic perspectives on the development of ADHD, describing models that emphasize shared etiological mechanisms and overlapping symptom dimensions across disorders.

1. Introduction

The transdiagnostic approach has become increasingly important in describing contemporary models of developmental psychopathology, as it seeks to identify underlying mechanisms that cut across traditional diagnostic categories. This perspective is particularly relevant in childhood, when disorders are marked by high comorbidity and overlapping symptom profiles. Among these, Attention-Deficit/Hyperactivity Disorder (ADHD) represents a paradigmatic example, given its complex clinical history and repeated reformulations of core symptom dimensions. Tracing the historical development of ADHD—from early descriptions of overarching behavioural syndromes to the later specification of its symptom clusters—highlights a recurring need to understand broader processes that may underpin this disorder.
Building on this foundation, recent studies have increasingly focused on transdiagnostic factors implicated in ADHD, including deficits in executive functioning, emotional dysregulation, social factors, and motivational systems. These mechanisms offer explanations for both the heterogeneity within ADHD and its frequent overlap with disorders such as autism spectrum disorder, oppositional defiant disorder, conduct disorder, anxiety disorders, depressive disorders, and substance use disorders. The following sections, therefore, outline the developmental history of ADHD in relation to overarching symptom domains, the rationale for a transdiagnostic framework, and summarise the key transdiagnostic theories currently proposed in the literature. Relevant literature was identified through searches in PsycINFO, PubMed, Web of Science, and Scopus. The search included relevant studies from 1957 to 2025, covering both foundational and contemporary studies on ADHD and transdiagnostic approaches.

1.1. History of ADHD

Attention-deficit/hyperactivity disorder (ADHD) was first described in a medical textbook by Weikard in 1775. At that time, it was used to characterize children and adults who exhibited inattention, distractibility, lack of persistence, excessive activity, and impulsivity [1]. Even then, the causes were attributed either to social factors (e.g., inadequate upbringing) or to certain biological predispositions. Following Weikard, a more detailed early description of ADHD was provided by Crichton in 1798, suggesting that attention deficits occur when attention cannot be sustained across situations, and distinguished between two types, situated at the opposite ends of a continuum: one due to reduced excitation of nerve cells, the other due to excessive sensitivity of nerve cells [2].
George Still’s lectures in 1902 offered the first systematic account of children with ADHD-like symptoms, emphasising excessive activity, aggressiveness, defiance, resistance to discipline, excessive emotionality (“passionateness”), spitefulness, cruelty, and dishonesty. Additionally, intentional control of behaviour was absent, and behaviour that defied the law was present. These children later exhibited higher rates of criminal behaviour, indicating a connection with conduct disorders as they are defined today. He linked these behaviours to deficits in “moral control,” involving self-awareness, working memory, behavioural inhibition, and rule-governed behaviour, which remain central to modern ADHD models [1].
During the encephalitis epidemic of 1917–1918 in North America, survivors frequently displayed impulsivity, attention and memory deficits, and socially deviant behaviours, indicating a possible link between brain damage and ADHD symptoms [1]. This led to the introduction of the paradigm of “minimal brain dysfunction” (MBD), which defined ADHD in terms of brain damage. One of the most prominent theories related to MBD, proposed by Wender [3], describes six groups of symptoms specific to this disorder, including hyperactivity, attentional and learning problems, poor impulse control, social difficulties, and emotional dysregulation. Despite limited empirical support, this model persisted for decades, influencing special education practices and clinical terminology.
By the mid-20th century, the concept evolved into “hyperkinetic-impulsive disorder” [1,4], characterised by hyperactivity, short attention span, poor concentration (especially in school settings), unpredictability and variability in performance, impulsivity, and difficulties with delayed gratification. In their study, Laufer et al. [4] attributed the occurrence of hyperkinetic-impulsive disorder to dysfunctions in the diencephalon, and to a lesser extent, to potential emotional imbalance. Unlike earlier models, later accounts began to separate ADHD from brain injury syndromes, moving away from parental blame and emphasising objective diagnostic criteria [1]. Douglas’s Attention Deficit Model [5,6,7] built upon this perspective, highlighting deficits in (a) engagement, organisation, and maintenance of attention, (b) inhibition of impulsive responding, (c) situational adjustment of arousal levels, and (d) an unusually strong need for immediate stimulation or gratification. Reflecting these changes, DSM-III [8] adopted the term “Attention Deficit Disorder” (ADD), placed greater emphasis on sustaining attention and impulse control rather than hyperactivity, and introduced subtypes with and without hyperactivity. These changes conflicted with ICD-9 criteria, which retained hyperactivity as a central symptom.
The next milestone came with neuroimaging research, as Zametkin et al. [9] demonstrated reduced glucose metabolism in the frontal and striatal regions of adults with childhood-diagnosed ADHD. At the same time, evidence emphasising the significance of genetic factors in the development of ADHD emerged [10,11]. Together, these findings provided the basis for the current understanding and description of the disorder. The following sections address diagnostic criteria, subtypes, primary symptoms, and recent theoretical developments for the transdiagnostic approach to ADHD in more detail.

1.2. Diagnostic Criteria, Subtypes, and Primary Symptoms of ADHD

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder defined by two clear and related behavioural dimensions: attention and hyperactive–impulsive behaviour [12]. These underlie a range of observed symptoms and appear with greater intensity than would be expected at the observed level of development [13]. Symptoms typically emerge between ages three and four [14], with the ICD-11 indicating onset by age twelve [15].
According to DSM-5, ADHD involves a “persistent pattern of inattention and/or hyperactivity–impulsivity that interferes with functioning or development” [12]. Inattention is reflected in errors, poor concentration, and disorganisation, while hyperactivity and impulsivity involve excessive motor activity, restlessness, or sudden, risk-prone actions.
The ICD-11 [15] (under mental, behavioural or neurodevelopmental disorders section, Attention deficit hyperactivity disorder subsection) defines ADHD as a “disorder characterised by long-lasting (at least six months) patterns of inattention and/or hyperactivity–impulsivity that have a direct negative impact on academic, occupational, or social functioning, and which must be present in multiple settings.” Inattention is defined as significant difficulty in sustaining attention during tasks that are not highly stimulating and frequently rewarding, as well as distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulty remaining still, most evident in structured situations. Impulsivity is defined as a tendency to respond immediately to a stimulus without thinking or considering the consequences and risks. Although there are minor differences in the way ADHD is defined depending on the classification system, these differences are minimal and primarily related to the organisation of the text in the manuals, rather than reflecting clear and clinically significant differences in the definition of the disorder. A direct comparison of the diagnostic criteria as listed in the DSM-5 and ICD-11 classifications is presented later in the text (Table 1).
Table 1. Comparative overview of the DSM-5 and ICD-11 diagnostic criteria for attention-deficit/hyperactivity disorder [12] (pp. 59–66), [15] (under mental, behavioural or neurodevelopmental disorders section, Attention deficit hyperactivity disorder subsection).
Both manuals describe three subtypes: predominantly inattentive, predominantly hyperactive–impulsive, and combined presentation. Subtype assignment depends on whether diagnostic thresholds are met for one or both symptom domains over a six-month period [12,15].
Both classification systems [12] (pp. 59–66), [15] (under mental, behavioural or neurodevelopmental disorders section, Attention deficit hyperactivity disorder subsection) also list a number of disorders that share certain characteristics with ADHD. The following is the description of characteristics (in brackets) that are shared between ADHD and various disorders: “oppositional defiant disorder (resistance to work or school tasks), intermittent explosive disorder (high levels of impulsive behaviour), specific learning disorder (inattention in academic situations), intellectual disability (mismatch between academic demands and individual ability), autism spectrum disorder (inattention, social dysfunction, and difficulties in behaviour management), developmental coordination disorder (clumsiness), reactive attachment disorder (social disinhibition), anxiety disorders (inattention), depressive disorders (poor concentration), bipolar disorder (increased activity, poor concentration, and increased impulsivity), disruptive mood dysregulation disorder (pervasive irritability and frustration intolerance), substance use disorders (differences in differential diagnosis and timing of symptom onset), personality disorders (disorganisation, social intrusiveness, and problems with emotional and cognitive regulation), psychotic disorders (inattention and hyperactivity), medication-induced ADHD symptoms, and neurocognitive disorders (onset timing).
Comorbidity of ADHD with other disorders is relatively common and includes oppositional defiant disorder (ODD), conduct disorder (CD), disruptive mood dysregulation disorder, specific learning disorder, anxiety disorders, major depressive disorder, intermittent explosive disorder, substance use disorders, antisocial and other personality disorders, obsessive–compulsive disorder, tic disorders, and autism spectrum disorder.

1.3. Transdiagnostic Approach to Developmental Psychopathology

The paradigm for interpreting the aetiology of disorders has changed over the years. The beginnings were marked by an emphasis on the importance of a larger number of shared causes that can be found at the basis of a range of disorders (multifinality), while the later focus, particularly following the publication of the DSM-III, shifted towards describing specific causes of individual disorders, based on the assumption that different causes are associated with specific categories of disorders (equifinality). This manner of describing, understanding, and treating disorders remains dominant today, and two taxonomies have become the “gold standard” within this approach: the Diagnostic and Statistical Manual of Mental Disorders (currently the fifth edition, DSM-5) [16] and the International Classification of Diseases and Related Health Problems (currently 11th edition, ICD-11) [16,17]. This approach enabled easier access to, and communication about, mental disorders among professionals, service providers, and researchers; it facilitated the planning of programmes and treatments, as well as their evaluation [18], and it reduced potential stigma and prejudice towards mental disorders [17].
However, there are several limitations of classical taxonomies that necessitate the search for new classification systems. One of the most important criticisms of traditional taxonomies lies in defining disorders as distinct categories, neglecting a dimensional approach (although DSM-5 has started using a dimensional approach to describe some disorders (Alternative Model for Personality Disorders and Autism Spectrum Disorder)), increasing the loss of significant information, and fostering potential diagnostic errors [19,20]. Furthermore, traditional classification systems contain an exceptionally large number of different disorders, making it impossible for individual clinicians to be familiar with them all [19]. In addition, this approach leads to reduced reliability [21], constrains the heterogeneity of disorders [22], diminishes the importance of comorbidity—which may indicate a shared basis of different disorders—and inadequately treats individuals who do not clearly fit into a particular disorder but nevertheless report certain difficulties in functioning [19,23]. It also may potentially cause the loss of information [20], lead to poorer discrimination between qualitatively different disorders and result in the same diagnosis being assigned to individuals with different symptoms (for example, 16,400 different symptom profiles describe major depressive disorder) [24]. When constructing such a taxonomy, it is necessary to define prototypical symptoms of a specific disorder, which inevitably leads to neglecting certain symptoms and may result in poor validity of clinical instruments.
Another criticism, one well known to researchers and clinicians working in developmental psychopathology, concerns changes in the significance and expression of symptoms across development. Classical taxonomy allows for such changes to some extent, but it ultimately defines them in terms of different disorders.
On the other hand, it is precisely the long-standing investigation of the influence of different factors on the development of disorders—focusing on individual symptoms and disorders—that has provided the basis for shifting attention towards fundamental underlying mechanisms (cognitive, behavioural, emotional, or physiological) described by the transdiagnostic approach. The importance of this approach lies in facilitating the understanding of fundamental dysfunctional processes, as well as the nature of psychopathological phenomena, understanding comorbidity between disorders, and enabling the planning of psychological treatments for a wider range of clinical problems by focusing on the core processes that underlie them [25,26]. For a transdiagnostic model to be meaningful, it must be able to describe the relationship between the development of different disorders and a specific category of causes (a transdiagnostic factor). Such a model can describe the mechanisms underlying multifinality, define factors that influence the development of different disorders in different people, or different disorders within the same person over time (i.e., different developmental trajectories of disorders) [26].
According to Kotov et al. [23], the transdiagnostic approach emerged very early in the interpretation of the aetiology of disorders, in the first attempts at factor analyses of items used to describe psychopathology symptoms and cluster analyses to define groups. Although these two types of analyses differ, the interpretation of their results is expressed in terms of describing shared categories across multiple disorders. This approach was also used in personality psychology when describing the hierarchical taxonomy of personality, from specific facets to broad personality traits [27,28].
The two best-known systems for classifying disorders based on the transdiagnostic approach are HiToP (Hierarchical Taxonomy of Psychopathology) [23] and RDoC (Research Domain Criteria) [29]. The aim of the HiToP classification is to “develop an empirically driven classification system based on advances in quantitative research on the organization of psychopathology. Primary objectives are to integrate evidence generated by this research to date, and produce a system that reflects a synthesis of existing studies.” [23] (p. 4). This approach completely rejects the traditional diagnostic system and introduces its own concepts in describing psychopathology.
An example of the HiToP taxonomy involves a series of signs and symptoms grouped into maladaptive traits describing disorders such as antisocial personality disorder, conduct disorder, oppositional defiant disorder, attention-deficit/hyperactivity disorder, and intermittent explosive disorder. These disorders are grouped under the subfactor of antisocial behaviour, which is further classified into two spectra—the disinhibited and antagonistic externalising spectra—and finally placed within a single superspectrum [19,23] (for a detailed figure, see [23], p. 43).
A second example, which is in fact one of the precursors of this classification, is offered by [19] in their book Cognitive Behavioural Processes Across Psychological Disorders: A Transdiagnostic Approach to Research and Treatment. In this book, the authors define a set of transdiagnostic factors, including attention (selective attention to external and internal stimuli and safety-focused attention), memory (expressive selective memory and repetitive memory), reasoning (interpretative reasoning, expectancy-based reasoning, and emotional reasoning), thinking (repetitive thinking, positive and negative metacognitive beliefs), and behaviour (excessive avoidance and safety behaviours) related to cognitive-behavioural processes and their significance for a range of disorders, such as anxiety disorders, somatoform disorders, dissociative disorders, gender identity disorders, eating, feeding, and sleeping disorders, impulse control disorders, mood disorders, schizophrenia and other psychotic disorders, and substance-related and addictive disorders. This approach does rely on traditional diagnoses, but the emphasis on cognitive-behavioural processes underlying a range of disorders is what makes it a precursor to the transdiagnostic approach.
The second alternative classification, RDoC, also emerged as an attempt to address the limitations of traditional taxonomy. This classification arose from the need for a new approach to diagnosing schizophrenia and is part of projects by the U.S. National Institute of Mental Health (NIMH) [29,30]. One aim was to group various constructs related to schizophrenia into overarching domains, including negative affect, positive affect, cognition, social processes, and arousal/regulatory systems. However, the primary goal of this approach has always been to define a new classification system based on dimensions of observed behaviour and neurobiological processes [29,31]. This classification also includes methods for collecting and analysing data, such as genetic, molecular, behavioural, or self-report measures.
Furthermore, RDoC defines constructs relevant to psychopathology as increased dysregulation in functionality, which can be described as extremes at either end of the normal distribution [32]. An example of research that fits within the RDoC taxonomy was a study conducted by Parkes et al. [33], who aimed to investigate whether dimensions of psychopathology could be linked to individual differences in deviations from normative neurodevelopment. They proposed a model, which includes a general factor of psychopathology (p-factor) and five specific factors encompassing symptoms of anxiety and mood changes, externalising behaviour, fear, and positive and negative psychotic symptoms. These psychopathology dimensions were associated with results obtained using brain imaging techniques and normative modelling (a statistical modelling approach examining expected associations between age and brain characteristics). Based on the normative model, which represents the relationship between age and expected brain structures and functions, regional changes can be identified, and it can be determined whether these changes predict psychopathology dimensions in the general population. Similar brain changes are also expected across different disorders, explained by the p-factor, alongside specific changes corresponding to other psychopathology factors. Although both HiToP and RDoC are based on the transdiagnostic approach, these two taxonomies emphasise either clinical phenomena (HiToP) or biological processes in psychopathology (RDoC). Since RDoC is mainly focused on basic biological processes and pathological behaviour, it is limited in its ability to describe clinical phenomena, leaving room for the structured characterisation of dimensions concerning psychiatric phenotypes. Additionally, the reorganisation of psychiatric nosology, which has been widely used for a considerable amount of time, means that the clinical application of RDoC findings remains a prospect for the future. HiToP, on the other hand, offers descriptions of clinical phenomena and adresses the shortcomings of classical nosology systems. However, its limitations are reflected in the descriptive nature of clinical dimensions and the possibility of omitting disorders with multiple clinical manifestations [23]. Therefore, various authors [34,35,36,37] suggest that these two taxonomies could potentially be integrated into a single classification system. Validation studies, largely associated with the RDoC approach, could be highly valuable for defining the aetiology, pathophysiology, and treatment planning of the dimensions described by HiToP. Additionally, HiToP provides well-defined core phenotypic dimensions that can inform the definition of biological and behavioural constructs, while RDoC integrates information from multiple approaches to define psychopathology.
The transdiagnostic approach is not without its limitations. Harvey et al. [19] and Ollendick et al. [38] note that it is difficult for the transdiagnostic approach to account for variability in symptom presentation across different disorders. Fusar-Poli et al. [39], in their systematic review of transdiagnostic research, highlight substantial heterogeneity and a lack of standardisation in defining what constitutes a transdiagnostic approach. They also note the limited real contribution of this approach to the formation of new diagnostic classifications, comparing its dimensional approach with the DSM-5 dimensional approach to personality disorders.
Finally, a transdiagnostic approach may offer an important perspective in defining changes in the significance and the expression of symptoms across development, and such a perspective is highly useful when tracking the development of complex disorders, such as ADHD, which includes cognitive, behavioural, and emotional symptoms.

2. Transdiagnostic Theories of ADHD Development

ADHD is a highly comorbid disorder in childhood, with most comorbidities shared with oppositional defiant disorder and conduct disorder. It belongs to a group of disorders that can be described through externalising behaviour (causing discomfort or conflict in the environment and being outward directed) and are characterised by aggression, delinquency, and hyperactivity [40]. Given the significant role of comorbidity and the often unclear clinical presentation of ADHD in childhood, there is an increasing need to identify transdiagnostic factors underlying this disorder. For example, Miller et al. [41] suggest a multidimensional, multi-informant, longitudinal approach to the study of ADHD to better understand the interaction of genes, brain, body, and the environment. These results should be analysed utilizing both sound and rigorous statistical approaches and theoretical approaches, keeping in mind a regulatory framework.
The first model fitting within the paradigm of transdiagnostic approaches is the multiple deficit model. According to this model, ADHD symptoms arise from an interactive combination of several neuropsychological weaknesses, none of which alone is sufficiently significant to cause the disorder. Specific clusters of these deficits differ between individuals, contributing to heterogeneity in ADHD symptom profiles [42,43]. This model focuses on multiple predictors shaping different symptom profiles or shared risk factors underlying comorbidity, including genetic and environmental influences, their interactions, brain activity, neuropsychological functioning, and behavioural symptoms [42]. For instance, deficits in executive control and processing speed are linked to inattention and learning difficulties, while executive function deficits, combined with delay aversion or other motivational processes, may produce impulsive behaviours and comorbid conduct disorders [44].
Pennington [43] outlined five core assumptions of the multiple deficit model: (1) aetiology of complex behavioural disorders is multifactorial; (2) risk and protective factors shape cognitive development, leading to behavioural symptoms of the disorder; (3) no single factor alone causes the disorder; (4) comorbidity is expected and arises from shared risk factors; and (5) disorders and symptoms are best conceptualised as continuous and qualitative rather than categorical and discrete. The model incorporates four levels of analysis: aetiological, neural, cognitive, and symptom-level (where symptom dimensions define the disorder). At the aetiological level, interactions and correlations between genes and the environment are examined. At the neural level, the impact of a single genetic or environmental risk factor on multiple neural systems (pleiotropy) is analysed. At the cognitive level, the relationships between different constructs are assessed, arising from overlapping developmental pathways and the interactive nature of cognition. Overlap at the cognitive level leads to comorbidity at the symptom level [43].
This model addresses prior limitations of single-deficit approaches and links shared risk factors, such as processing speed deficits, with dyslexia, dyscalculia, and ADHD, and speech difficulties with dyslexia and dyscalculia [45,46]. Limitations include reliance on cross-sectional studies and flexible causal explanations [43].
Another transdiagnostic approach, aligned with the Research Domain Criteria (RDoC) [29] system, focuses on the central role of stress coping and emotion regulation in the development of internalising and externalising problems [47]. In this approach, internalizing and externalizing problems are defined as dimensions. Emotional regulation and coping are viewed as domains consisting of factors such as emotion-focused coping, primary and secondary coping control, and disengaged coping, which are, in turn, manifested in specific coping and emotion regulation strategies, such as emotional expression and cognitive reappraisal. Furthermore, emotional regulation and coping are considered proximal risk factors connected with selection and modification of situations that evoke emotional reaction, attention, cognitive shift, or modulation of emotional responses [41,47,48]. Thus, emotion regulation serves as a moderator for situations with emotional responses and engagement of attention, cognitive change, with meta-analytic evidence showing moderate negative links between emotion regulation and internalising/externalising symptoms, and significant moderate positive associations between maladaptive coping and internalising symptoms [47,49].
Third approach, the developmental spectrum model of externalising psychopathology (called the ontogenetic process model of the externalising psychopathology) proposed by Beauchaine & McNulty (Correction published 12 March 2014) [50,51] includes a combination of RDoC and DSM approaches, where a single overarching factor of vulnerability for the development of externalising disorders, defined as susceptibility to externalisation (impulsivity trait), encompasses symptoms of ADHD, ODD, conduct disorder (CD), antisocial personality disorder, and substance use disorders. Impulsivity in this case is described as dysfunction in the mesolimbic dopamine pathway, and a preference for immediate reward, i.e., the inability to inhibit responses [52].
According to this model, symptoms of externalising disorders do not in fact describe distinct disorder categories, but rather describe different dimensions that can form various combinations of disorders (comorbidity). In this model, genetics has a significant influence on the development of vulnerability to externalising disorders, while environmental factors (shared and specific) are more relevant for specific behavioural dimensions (ADHD, ODD, etc.) [53,54]. It is clear that this approach fits within the RDoC paradigm, since it describes the significance of biological factors in the development of groups of disorders that comprise a single specific overarching factor (susceptibility to externalisation).
Thus, disorders from the externalising spectrum show pronounced comorbidity; their covariance can be almost entirely explained by a single overarching factor (susceptibility to externalisation), which is heritable, and is characterised by dysfunction of the mesolimbic dopamine system, behaviourally expressed as impulsivity. Furthermore, the specific expression of impulsivity in individual disorders is influenced by environmental factors [50,51].
Additionally, extension of this model was necessary to explain multifinality. The extension adds explanation ofheterotypic development of externalising disorders across age, and different levels of analysis, arranged from higher to lower: genetic vulnerability (epigenetic processes, vulnerability alleles), neural/hormonal substrates (amygdala functions, midbrain dopamine pathways, and prefrontal cortex), latent vulnerability traits (RDoC level), disorders (DSM and ICD level), and mediators of environmental risk (parenting quality, involvement in deviant groups, propensity for criminal behaviour, etc.).
Although the model described is complex, the authors of the model actually consider this necessary in order to encompass all levels and processes in developmental psychopathology. The highest order factor in these models is defined as susceptibility to externalisation (impulsivity trait), and represents the basic predisposing factor of vulnerability for the development of disorders from the externalising spectrum (disorder level), on which mediators of environmental risk act, potentially overlapping and changing during development. Susceptibility to externalisation arises as a result of various factors acting at the neural/hormonal level and genetic vulnerability, and can be amplified through recurring feedback loops present at almost all levels of analysis [49].
As presented, this model clearly belongs to the group of transdiagnostic models and is similar to the multiple deficit model of Pennington [43].
The next model, suggested by Burns et al. [55] is a bifactor model of the latent structure of ADHD/ODD symptoms. This bifactor model comprises a single higher-order factor, a general disruptive behaviour factor, and three specific factors: inattention, hyperactivity–impulsivity, and oppositionality. The model was derived from the dual-pathway/impulsivity trait framework, in which one pathway involves hyperactivity–impulsivity as a primary factor, which then influences the development of inattention and later the potential emergence of ODD and CD, while the second pathway reflects the development of inattention (frontal dysfunction), which shows weaker associations with ODD, CD, and impulsivity.
Harvey et al. [56] also outline two prominent transdiagnostic models of ADHD and ODD: the correlated risk factors model and the developmental precursor model. The correlated risk factors model assumes that common risk factors underlie comorbidity [57], emphasising genetic influences [54], while also incorporating environmental contributions [58]. This model underlines the role of family history of ADHD and ODD in describing ADHD and anger/irritability in children. The developmental precursor model sets ADHD as a precursor to ODD. The existence of ADHD in the family increases stress and affects family functioning (peer rejection, increased levels of stress and psychopathology in parents, and negative parenting styles), which in turn increases risk for the development of ODD [59,60,61].
The next transdiagnostic model of ADHD and ODD is based on the role of self-regulation (SR) in the development of ADHD, ODD, and ASD. Self-regulation has long been established as one of the most important tasks for preschool-aged children, along with the theory of mind and the relationship between the parents and the child [62]. Luman et al. [63] emphasise the mediating role of SR, specifically “hot” executive functions (EF), between ADHD and ODD. They found that children diagnosed with ODD perform more poorly on “hot” executive function (EF) tasks than controls, and that children diagnosed with ADHD and comorbid ODD perform more poorly on “hot” EF tasks (displaying more risk-taking behaviour) than children diagnosed with ADHD without comorbid ODD. This is further researched by Ros & Graziano [64], who proposed a transdiagnostic model emphasising the role of SR, and SR profiles in predicting response to treatment to various disorders, including ADHD and ASD. However, these authors [64] propose the addition of emotion regulation (ER) along with EF to SR profiles based on the assessments from both parents and teachers. The results of their study indicate high ER deficits in ADHD, and high EF deficits in ASD, but moderate deficits in both ER and EF for ADHD and ASD, with profile membership predicting treatment success regardless of the disorder. Similarly, the work of Nigg & Barkley [13] describes the association between ADHD and ODD through emotional dysregulation/impulsivity (EI-DESR). In this model, an individual, alongside the capacity to select and construct alternative behavioural responses to a given situation (EF), also possesses the capacity to select and construct alternative emotional responses (ER) to that same situation. Individuals with both ADHD and ODD will be equally inattentive during motor actions as during emotional actions, since these two components are connected, that is, unified in their response [1]. Consequently, to the extent that an individual exhibits difficulties related to behavioural impulsivity, they will exhibit difficulties related to emotional impulsivity to the same extent.
EFs are also shown to be transdiagnostic factors between ADHD and major depressive disorder (MDD), with attentional and executive dysfunctions as common factors, and cognitive flexibility, initiating, inhibition, and meta-cognition as differential factors [65]. A recent study from Tharaud & Nikolas [66] has shown two distinct pathways that include emotion regulation, ADHD, and depression. The first one emphasises the role of distraction as a dimension of ER in linking inattention and depression symptoms. The second one emphasises the role of the catastrophising dimension of ER in linking hyperactivity–impulsivity with depressed mood and anhedonia. Guineau et al. [67] have also shown anhedonia to be a significant predictor of the severity of symptoms for MDD, anxiety sensitivity, ADHD, and ASD.
Reaction time variability (RT variability) was also proposed as a transdiagnostic factor for ADHD and ASD. However, Karalunas et al. [68] suggest greater importance of RT variability when describing ADHD, and ASD only with comorbid ADHD, calling for the consideration of interaction between top-down control, state regulation, motor preparation in the interpretation of RT variability, and the superior role of decomposition of the RT signal. These suggestions are supported by the findings of Tye et al. [69], showing differences in RT variability between ADHD only and ADHD + ASD, and ASD only and typically developing controls. One recent study [70] emphasises the role of attention as a transdiagnostic factor for ADHD, ASD, anxiety, and hyper-vigilance. Hyper-vigilance, hyper-focus, and inattention were related to auditory hyper-reactivity, a symptom common in ASD and ADHD, as well as anxiety and hyper-vigilance.
Oddo et al. [71] have examined the transdiagnostic potential of shared factors between ADHD and Alcohol Use Disorder (AUD) and have found that a shared common factor among these two disorders is environmental suppressors (aversive/unpleasant experiences that prevent access to rewards). They have found that drinking enhances the probability of various social rewards and thus reinforces escape from unpleasant experiences, while the same type of suppression makes delaying gratification effortful and burdensome. Furthermore, Yoshimura et al. [72] have linked specific attention-deficit traits to AUD. In addition to this, Bartoli et al. [73] have shown that a portion of AUD in bipolar disorder relates to the comorbidity with ADHD.
Sonuga-Barke et al. [74] have suggested decision-making as a transdiagnostic factor in the development of ADHD, CD, depression, and anxiety. According to this model decision making includes three stages, namely evaluation (subjective estimates for outcomes), decision and management (comparison of subjective estimates, choice, and implementation of a plan to effectively enact the chosen option), and appraisal and accommodation (reinforced learning processes), including default mode network, executive control and reinforced learning, encoding of value, and emotion processing neurobiological substrates. This model hypothesizes that decision making in ADHD is deficient and impulsive, in CD it is reckless and insensitive to negative consequences, in depression it is disengaged, perserverative and pessimistic, and in anxiety it is hesitant, risk-averse, and self- deprecating. Furthermore, Pillny et al. [75] have also shown the maladaptive effort allocation across increasing reward and probability conditions for MDD, schizophrenia spectrum (SSD), anhedonia, and cognitive impairments.
Sluggish cognitive tempo (SCT) was also proposed as a transdiagnostic factor in the development of ADHD, EF deficits, and internalising symptoms [76]. Individual differences in SCT predict symptom scores on inattention and Hyperactivity-impulsivity, EF deficits, and internalising psychopathology, thus possibly contributing to the overlap of ADHD, EF deficits, and internalising psychopathology.
Finally, different transdiagnostic models and approaches could guide diagnosis and clinical intervention by better addressing the heterogeneity and comorbidity of disorders. Stanton et al. [77] emphasise the need for clinicians to assess a range of symptom dimensions across multiple psychopathological spectra rather than relying exclusively on categorical dimensions. This can be achieved through the use of assessment instruments capable of capturing multiple symptom dimensions, allowing for a more comprehensive representation of individual clinical profiles. Transdiagnostic approaches also provide a clearer framework for treatment planning, intervention, and clinical decision-making than DSM or ICD diagnoses alone. Relationships between symptoms and underlying mechanisms can be examined at both specific levels and broader categories, facilitating a more coherent understanding of disorder presentations. These approaches may better reflect heterogeneity and comorbidity observed in real-world clinical settings and thus offer greater flexibility in planning interventions. According to Dalgleish et al. [17], transdiagnostic interventions can be divided into two categories and vary in their breadth of application. The first category includes universal interventions applicable across a range of diagnoses, such as “The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders” [78]. The second category comprises modular interventions, allowing flexible and independent application of different evidence-based therapy modules to match the needs of every client, such as “The Modular Approach to Therapy for Anxiety, Depression, Trauma, or Conduct Problems” [79].

3. Gaps in Literature

Although substantial progress has been made in understanding ADHD, several important gaps remain. First, the interaction between genetic predispositions and environmental factors, such as prenatal exposures and early-life stress, is not fully clear, particularly with regard to the mechanisms through which these interactions shape neurodevelopmental trajectories and confer differential risk from symptom persistence or remission. Recent studies, such as Wang et al. [80] and Miller et al. [41], offer some insight into this gap, as they include a developmental and transdiagnostic framework; however, they are few and still not enough to clearly understand developmental mechanisms and trajectories of ADHD. Second, longitudinal studies tracking developmental trajectories from childhood into adolescence and adulthood exist [39,67], but in order to predict long-term outcomes or identify early markers of symptom persistence these types of studies are required in greater number, with emphasis on developmental transitions, sex differences, and various contextual moderators, such as life stress exposure, emotion regulation, prenatal family events, or theory of mind. Third, while multiple neurocognitive models have been proposed, the neural mechanisms underlying symptom heterogeneity and comorbidity with other disorders remain unclear, requiring an empirical integration of findings across genetic, neural, cognitive, and behavioural levels of analysis. Additionally, there is a need for studies examining how individual differences in cognitive, emotional, and motivational profiles can inform personalized interventions, particularly due to the multidimensional and heterogeneous nature of ADHD. This ties well with the research on the benefits of using a multidimensional, multi-informant approach and the integration of transdiagnostic and dimensional approaches. One example of such an approach is the Achenbach System of Empirically Based Assessment (ASEBA) [81], as it includes items relating to specific symptom dimensions, as well as broader dimensions of internalizing and externalizing problems, or MMPI-3 [82] for measuring broad dimensions of personality and psychopathology. Although such measurement instruments exist, their number is limited. Additionally, this research could lead to an increase in understanding the applicability of the multidimensional and transdiagnostic approach in routine clinical assessment, treatment planning, and prevention strategies. Finally, an additional consideration concerns the cross-cultural validity of transdiagnostic approaches. Most dominant transdiagnostic approaches, such as RDoC and HiToP, have been developed and empirically tested primarily in American and European samples. These approaches may offer advantages in cross-cultural settings due to their focus on underlying processes and symptom dimensions; however, empirical validation remains limited [83]. One recent review, conducted by Rodriguez-Seijas et al. [84], suggests a limited cross-cultural applicability of HiToP, specifically regarding internalizing and externalizing domains, but also emphasises the need for further empirical validation.
Addressing these gaps could significantly improve early detection, intervention design, and treatment outcomes for individuals with ADHD, while also contributing to a more coherent theoretical framework.

4. Conclusions

ADHD is a complex neurodevelopmental disorder, characterised by heterogeneous cognitive, behavioural, and emotional profiles. Current evidence highlights the interplay of genetic, environmental, and neurobiological factors in its aetiology and manifestation. Early identification and targeted interventions remain crucial, yet a comprehensive understanding of individual differences in symptom presentation, comorbidities, and treatment response is still evolving. Continued integration of genetic, neuroimaging, and behavioural research promises to refine diagnostic and therapeutic strategies.

Author Contributions

Conceptualization, B.B. and K.K.J.; investigation, B.B.; writing—original draft preparation B.B.; writing—review and editing, K.K.J. and B.B.; visualization, K.K.J.; supervision, K.K.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Barkley, R.A. Emotional Dysregulation Is a Core Component of ADHD. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis & Treatment; Barkley, R.A., Ed.; The Guilford Press: New York, NY, USA, 2018; pp. 81–116. [Google Scholar]
  2. Palmer, E.D.; Finger, S. An early description of ADHD (Inattentive subtype): Dr. Alexander Crichton and “Mental Restlessness” (1798). Child Psychol. Psychiatry Rev. 2001, 6, 66–73. [Google Scholar] [CrossRef] [Scilit]
  3. Wender, P.H. Minimal Brain Disfunction in Children: Diagnosis and Management. Pediatr. Clin. N. Am. 1973, 20, 187–202. [Google Scholar] [CrossRef] [Scilit]
  4. Laufer, M.; Denhoff, E.; Solomons, G. Hyperkinetic impulse disorder in children’s behavior problems. Psychosom. Med. 1957, 19, 38–49. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Douglas, V.I. Higher mental processes in hyperactive children: Implications for training. In Treatment of Hyperactive and Learning Disordered Children: Current Research; Knights, R., Bakker, D., Eds.; University Park Press: Baltimore, MD, USA, 1980; pp. 65–92. [Google Scholar]
  6. Douglas, V.I. Treatment and training approaches to hyperactivity: Establishing internal or external control. In Hyperactive Children: The Social Ecology of Identification and Treatment; Whalen, C., Henker, B., Eds.; Academic Press: New York, NY, USA, 1980; pp. 283–318. [Google Scholar]
  7. Douglas, V.I. Attention and cognitive problems. In Developmental Neuropsychiatry; Rutter, M., Ed.; Guilford Press: New York, NY, USA, 1983; pp. 280–329. [Google Scholar]
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed.; American Psychiatric Association: Washington, DC, USA, 1980. [Google Scholar]
  9. Zametkin, A.J.; Nordahl, T.E.; Gross, M.; King, A.C.; Semple, W.E.; Rumsey, J.; Hamburger, S.; Cohen, R.M. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 1990, 323, 1261–1366. [Google Scholar] [CrossRef] [Scilit]
  10. Gjone, H.; Stevenson, J.; Sundet, J.M. Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35, 588–596. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Silberg, J.; Rutter, M.; Meyer, J.; Maes, H.; Hewitt, J.; Simonoff, E.; Pickles, A.; Loeber, R.; Eaves, L. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J. Child Psychol. Psychiatry 1996, 37, 803–816. [Google Scholar] [CrossRef] [Scilit]
  12. Američka Psihijatrijska Udruga. Dijagnostički i Statistički Priručnik za Duševne Poremećaje (DSM-5): Peto Izdanje; Naklada Slap: Zagreb, Croatia, 2014. [Google Scholar]
  13. Nigg, J.T.; Barkley, R.A. Attention Deficit/Hyperactivity Disorder. In Child Psychopathology, 3rd ed.; Mash, E.J., Barkley, R.A., Eds.; The Guilford Press: New York, NY, USA, 2014; pp. 75–145. [Google Scholar]
  14. Applegate, B.; Lahey, B.B.; Hart, E.L.; Waldman, I.; Biederman, J.; Hynd, G.W.; Barkley, R.A.; Ollendick, T.; Frick, P.J.; Greenhill, L.; et al. Validity of the age-of-onset criterion for ADHD: A report from the DSM-IV field trials. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36, 1211–1221. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 11th ed.; World Health Organisation: Geneva, Switzerland, 2019; Available online: https://icd.who.int/ (accessed on 5 February 2026).
  16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), 5th ed.; Text Revision; American Psychiatric Publishing: Washington, DC, USA, 2022. [Google Scholar]
  17. Dalgleish, T.; Black, M.; Johnston, D.; Bevan, A. Transdiagnostic approaches to mental health problems: Current status and future directions. J. Consult. Clin. Psychol. 2020, 88, 179–195. [Google Scholar] [CrossRef] [Scilit]
  18. Hayes, S.C.; Hofmann, S.G. Process-Based CBT: The Science and Core Clinical Competencies of Cognitive Behavioral Therapy; New Harbinger Publications: Oakland, CA, USA, 2018. [Google Scholar]
  19. Harvey, A.G.; Watkins, E.; Mansell, W.; Shafran, R. Cognitive Behavioural Processes across Psychological Disorders: A Transdiagnostic Approach to Research and Treatment; Oxford University: Oxford, UK, 2004. [Google Scholar]
  20. Markon, K.E.; Chmielewski, M.; Miller, C.J. The reliability and validity of discrete and continuous measures of psychopathology: A quantitative review. Psychol. Bull. 2011, 137, 856–879. [Google Scholar] [CrossRef] [Scilit]
  21. Markon, K.E. Epistemological pluralism and scientific development: An argument against authoritative nosologies. J. Pers. Disord. 2013, 27, 554–579. [Google Scholar] [CrossRef] [Scilit]
  22. Zimmerman, M.; Ellison, W.; Young, D.; Chelminski, I.; Dalrymple, K. How many different ways do patients meet the diagnostic criteria for major depressive disorder? Compr. Psychiatry 2015, 56, 29–34. [Google Scholar] [CrossRef] [Scilit]
  23. Kotov, R.; Krueger, R.F.; Watson, D.; Achenbach, T.M.; Althoff, R.R.; Bagby, R.M.; Brown, T.A.; Carpenter, W.T.; Caspi, A.; Clark, L.A.; et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J. Abnorm. Psychol. 2017, 126, 454–477. [Google Scholar] [CrossRef] [Scilit]
  24. Fried, E.I.; Nesse, R.M. Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. J. Affect. Disord. 2015, 172, 96–102. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  25. Ehrenreich-May, J.; Chu, B.C. Overview of transdiagnostic mechanisms and treatments for youth psychopathology. In Transdiagnostic Treatments for Children and Adolescents: Principles and Practice; Ehrenreich-May, J., Chu, B.C., Eds.; The Guilford Press: New York, NY, USA, 2013; pp. 3–14. [Google Scholar]
  26. Nolen-Hoeksema, S.; Watkins, E.R. A heuristic for developing transdiagnostic models of psychopathology: Explaining multifinality and divergent trajectories. Perspect. Psychol. Sci. 2011, 6, 589–609. [Google Scholar] [CrossRef] [Scilit]
  27. Costa, P.T.; McCrae, R.R. Normal personality assessment in clinical practice: The NEO Personality Inventory. Psychol. Assess. 1992, 4, 5–13. [Google Scholar] [CrossRef]
  28. Eysenck, H.J.; Eysenck, S.B.G. Manual of the Eysenck Personality Questionnaire; Hodder and Stoughton: London, UK, 1975. [Google Scholar]
  29. Cuthbert, B.N.; Insel, T.R. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med. 2013, 11, 126. [Google Scholar] [CrossRef] [Scilit]
  30. National Institute of Mental Health (NIMH). About RDoC. Available online: https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/about-rdoc (accessed on 28 January 2026).
  31. Insel, T.; Cuthbert, B.; Garvey, M.; Heinssen, R.; Pine, D.S.; Quinn, K.; Sanislow, C.; Wang, P. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167, 748–751. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Cuthbert, B.N. Research domain criteria: Toward future psychiatric nosologies. Dialogues Clin. Neurosci. 2015, 17, 89–97. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Parkes, L.; Moore, T.M.; Calkins, M.E.; Cook, P.A.; Cieslak, M.; Roalf, D.R.; Wolf, D.H.; Gur, R.C.; Gur, R.E.; Satterthwaite, T.D.; et al. Transdiagnostic dimensions of psychopathology explain individuals’ unique deviations from normative neurodevelopment in brain structure. Transl. Psychiatry 2021, 11, 232. [Google Scholar] [CrossRef] [Scilit]
  34. Patrick, C.J.; Hajcak, G. RDoC: Translating promise into progress. Psychophysiology 2016, 53, 415–424. [Google Scholar] [CrossRef] [Scilit]
  35. Michelini, G.; Palumbo, I.M.; DeYoung, C.G.; Latzman, R.D.; Kotov, R. Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience. Clin. Psychol. Rev. 2021, 86, 102025. [Google Scholar] [CrossRef] [Scilit]
  36. Davis, C.N.; Khan, Y.; Toikumo, S.; Jinwala, Z.; Boomsma, D.I.; Levey, D.F.; Gelernter, J.; Kember, R.L.; Kranzler, H.R. Integrating HiTOP and RDoC frameworks Part I: Genetic architecture of externalizing and internalizing psychopathology. Psychol. Med. 2025, 55, e138. [Google Scholar] [CrossRef] [Scilit]
  37. Davis, C.N.; Khan, Y.; Toikumo, S.; Jinwala, Z.; Boomsma, D.I.; Levey, D.F.; Gelernter, J.; Kember, R.L.; Kranzler, H.R. Integrating HiTOP and RDoC frameworks Part II: Shared and distinct biological mechanisms of externalizing and internalizing psychopathology. Psychol. Med. 2025, 55, e137. [Google Scholar] [CrossRef] [Scilit]
  38. Ollendick, T.H.; Benoit, K.E.; Grills-Taquechel, A.E. Social anxiety disorder in children and adolescents. In The Wiley Blackwell Handbook of Social Anxiety Disorder; Weeks, J.W., Ed.; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2014; pp. 179–200. [Google Scholar]
  39. Fusar-Poli, P.; Solmi, M.; Brondino, N.; Davies, C.; Chae, C.; Politi, P.; Borgwardt, S.; Lawrie, S.M.; Parnas, J.; McGuire, P. Transdiagnostic psychiatry: A systematic review. World Psychiatry 2019, 18, 192–207. [Google Scholar] [CrossRef] [Scilit]
  40. Liu, J. Childhood externalizing behavior: Theory and implications. J. Child Adolesc. Psychiatr. Nurs. 2004, 17, 93–103. [Google Scholar] [CrossRef] [Scilit]
  41. Miller, M.; Arnett, A.B.; Shephard, E.; Charman, T.; Gustafsson, H.C.; Joseph, H.M.; Karalunas, S.; Nigg, J.T.; Polanczyk, G.V.; Sullivan, E.L.; et al. Delineating early developmental pathways to ADHD: Setting an international research agenda. JCPP Adv. 2023, 3, e12144. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  42. McGrath, L.M.; Peterson, R.L.; Pennington, B.F. The multiple deficit model: Progress, problems, and prospects. Sci. Stud. Read. 2020, 24, 7–13. [Google Scholar] [CrossRef] [Scilit]
  43. Pennington, B.F. From single to multiple deficit models of developmental disorders. Cognition 2006, 101, 385–413. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  44. Willcutt, E.G. Theories of ADHD. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis & Treatment; Barkley, R.A., Ed.; The Guilford Press: New York, NY, USA, 2018; pp. 391–405. [Google Scholar]
  45. McGrath, L.M.; Pennington, B.; Shanahan, M.A.; Santerre-Lemmon, L.E.; Barnard, H.D.; Willcutt, E.G.; DeFries, J.C.; Olson, R.K. A multiple deficit model of reading disability and attention-deficit/hyperactivity disorder: Searching for shared cognitive deficits. J. Child Psychol. Psychiatry 2011, 52, 547–557. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  46. Peterson, C.C.; Wellman, H.M.; Slaughter, V. The mind behind the message: Advancing theory of mind scales for typically developing children, and those with deafness, autism, or Asperger Syndrome. Child Dev. 2012, 83, 469–485. [Google Scholar] [CrossRef] [Scilit]
  47. Compas, B.E.; Jaser, S.; Bettis, A.H.; Watson, K.H.; Gruhn, M.; Dunbar, J.P.; Williams, E.; Thigpen, J.C. Coping, emotion regulation and psychopathology in childhood and adolescence: A meta-analysis and narrative review. Psychol. Bull. 2017, 143, 939–991. [Google Scholar] [CrossRef] [Scilit]
  48. Lazarus, R.; Folkman, S. Stress, Appraisal, and Coping; Springer: New York, NY, USA, 1984. [Google Scholar]
  49. Gross, J.J.; Thompson, R.A. Emotion regulation: Conceptual foundations. In Handbook of Emotion Regulation; Gross, J.J., Ed.; Guilford Press: New York, NY, USA, 2007; pp. 3–24. [Google Scholar]
  50. Beauchaine, T.P.; McNulty, T. Comorbidities and continuities as ontogenic processes: Toward a developmental spectrum model of externalizing psychopathology. Dev. Psychopathol. 2013, 25, 1505–1528. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  51. Beauchaine, T.P.; McNulty, T. Corrigendum: Comorbidities and continuities as ontogenic processes: Toward a developmental spectrum model of externalizing psychopathology. Dev. Psychopathol. 2014, 26, 577. [Google Scholar] [CrossRef] [Scilit]
  52. Kamradt, J.M.; Nigg, J.T.; Friderici, K.H.; Nikolas, M.A. Neuropsychological performance measures as intermediate phenotypes for attention-deficit/hyperactivity disorder: A multiple mediation analysis. Dev. Psychopathol. 2017, 29, 259–272. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  53. Burt, S.A. Rethinking environmental contributions to child and adolescent psychopathology: A meta-analysis of shared environmental influences. Psychol. Bull. 2009, 135, 608–637. [Google Scholar] [CrossRef] [Scilit]
  54. Tuvblad, C.; Zheng, M.; Raine, A.; Baker, L.A. A common genetic factor explains the covariation among ADHD, ODD, and CD symptoms in 9–10 year old boys and girls. J. Abnorm. Child Psychol. 2009, 37, 153–167. [Google Scholar] [CrossRef] [Scilit]
  55. Burns, G.L.; Servera, M.; del Mar Bernad, M.; Carrillo, J.M.; Geiser, C. Ratings of ADHD symptoms and academic impairment by mothers, fathers, teachers, and aides: Construct validity within and across settings as well as occasions. Psychol. Assess. 2014, 26, 1247–1258. [Google Scholar] [CrossRef] [Scilit]
  56. Harvey, E.A.; Breaux, R.P.; Lugo-Candelas, C.I. Early development of comorbidity between symptoms of attention deficit hyperactivity disorder and oppositional defiant disorder. J. Abnorm. Psychol. 2016, 125, 154–167. [Google Scholar] [CrossRef] [Scilit]
  57. Rhee, S.H.; Willcutt, E.G.; Hartman, C.A.; Pennington, B.F.; DeFries, J.C. Test of alternative hypotheses explaining the comorbidity between attention-deficit/hyperactivity disorder and conduct disorder. J. Abnorm. Child Psychol. 2008, 36, 29–40. [Google Scholar] [CrossRef] [Scilit]
  58. Burt, S.A.; Krueger, R.F.; McGue, M.; Iacono, W.G. Sources of covariation among attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder: The importance of shared environment. J. Abnorm. Psychol. 2001, 110, 516–525. [Google Scholar] [CrossRef]
  59. Barkley, R.A. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 3rd ed.; Guilford Press: New York, NY, USA, 2006. [Google Scholar]
  60. Beauchaine, T.P.; Hinshaw, S.P.; Pang, K. Comorbidity of attention-deficit/hyperactivity disorder and early-onset conduct disorder: Biological, environmental, and developmental mechanisms. Clin. Psychol. Sci. Pract. 2010, 17, 327–336. [Google Scholar] [CrossRef] [Scilit]
  61. Hoza, B.; Mrug, S.; Gerdes, A.C.; Hinshaw, S.P.; Bukowski, W.M.; Gold, J.A.; Kraemer, H.C.; Pelham, W.E., Jr.; Wigal, T.; Arnold, L.E. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J. Consult. Clin. Psychol. 2005, 73, 411–423. [Google Scholar] [CrossRef] [Scilit]
  62. Cicchetti, D. Developmental psychopathology. In Developmental Psychopathology: Vol. 1. Theory and Method, 2nd ed.; Cicchetti, D., Cohen, D.J., Eds.; Wiley: Hoboken, NJ, USA, 2006; pp. 1–23. [Google Scholar]
  63. Luman, M.; Tripp, G.; Scheres, A. Identifying the neurobiology of altered reinforcement sensitivity in ADHD: A review and research agenda. Neurosci. Biobehav. Rev. 2010, 34, 744–754. [Google Scholar] [CrossRef] [Scilit]
  64. Ros, R.; Graziano, P.A. Group PCIT for Preschoolers with Autism Spectrum Disorder and Externalizing Behavior Problems. J. Child Fam. Stud. 2019, 28, 1294–1303. [Google Scholar] [CrossRef] [Scilit]
  65. van Hal, R.; Geurts, D.; van Eijndhoven, P.; Kist, J.; Collard, R.M.; Tendolkar, I.; Vrijsen, J.N. A transdiagnostic view on MDD and ADHD: Shared cognitive characteristics? J. Psychiatr. Res. 2023, 165, 315–324. [Google Scholar] [CrossRef] [Scilit]
  66. Tharaud, J.B.; Nikolas, M.A. Emotion regulation as a transdiagnostic link between ADHD and depression symptoms: Evidence from a network analysis of youth in the ABCD study. Child Adolesc. Psychiatry Ment. Health 2025, 19, 113. [Google Scholar] [CrossRef] [Scilit]
  67. Guineau, M.G.; Ikani, N.; Rinck, M.; Collard, R.M.; van Eijndhoven, P.; Tendolkar, I.; Schene, A.H.; Becker, E.S.; Vrijsen, J.N. Anhedonia as a transdiagnostic symptom across psychological disorders: A network approach. Psychol. Med. 2023, 53, 3908–3919. [Google Scholar] [CrossRef] [Scilit]
  68. Karalunas, S.L.; Geurts, H.; Konrad, K.; Bender, S.; Nigg, J.T. Annual Research Review: Reaction time variability in ADHD and autism spectrum disorders—Measurement and mechanisms of a proposed trans-diagnostic phenotype. J. Child Psychol. Psychiatry 2014, 55, 685–710. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  69. Tye, C.; Johnson, K.A.; Kelly, S.P.; Asherson, P.; Kuntsi, J.; Ashwood, K.L.; Azadi, B.; Bolton, P.; McLoughlin, G. Response time variability under slow- and fast-incentive conditions in children with ASD, ADHD and ASD + ADHD. J. Child Psychol. Psychiatry 2016, 57, 1414–1423. [Google Scholar] [CrossRef] [Scilit]
  70. Dwyer, P.; Williams, Z.J.; Lawson, W.; Rivera, S.M. A trans-diagnostic investigation of attention and diverse phenotypes of “auditory hyperreactivity” in autism, ADHD, and the general population. J. Atten. Disord. 2026, 30, 57–81. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  71. Oddo, L.E.; Acuff, S.F.; Arenson, M.B.; Oshri, A.; Chronis-Tuscano, A.; MacKillop, J.; Murphy, J.G. Unique and transdiagnostic dimensions of reward functioning in Attention-Deficit/Hyperactivity Disorder and Alcohol Use Disorder symptoms. Alcohol Alcohol. 2022, 57, 452–459. [Google Scholar] [CrossRef] [Scilit]
  72. Yoshimura, A.; Matsushita, S.; Kimura, M.; Yoneda, J.-I.; Maesato, H.; Yokoyama, A.; Higuchi, S. Influence of ADHD, especially attention-deficit characteristics, on the course of alcohol-dependent individuals. BMC Psychiatry 2022, 22, 803. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  73. Bartoli, F.; Callovini, T.; Calabrese, A.; Cioni, R.M.; Riboldi, I.; Crocamo, C.; Carrà, G. Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis. Brain Sci. 2022, 12, 38. [Google Scholar] [CrossRef] [Scilit]
  74. Sonuga-Barke, E.J.S.; Cortese, S.; Fairchild, G.; Stringaris, A. Annual research review: Transdiagnostic neuroscience of child and adolescent mental disorders—differentiating decision making in attention-deficit/hyperactivity disorder, conduct disorder, depression, and anxiety. J. Child Psychol. Psychiatry 2016, 57, 321–349. [Google Scholar] [CrossRef] [Scilit]
  75. Pillny, M.; Renz, K.E.; Lincoln, T.; Lütje, F.; Hay, A.; Fulford, D.; Barch, D.M.; Gold, J.M.; Kaiser, S. Effort-Based Decision-Making in Psychopathology: A transdiagnostic multilevel meta-analysis. OSF 2024. [Google Scholar] [CrossRef] [Scilit]
  76. Kamradt, J.M.; Eadeh, H.M.; Nikolas, M.A. Sluggish Cognitive Tempo as a Transdiagnostic Link Between Adult ADHD and Internalizing Symptoms. J. Psychopathol. Behav. Assess. 2022, 44, 699–712. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  77. Stanton, K.; McDonnell, C.G.; Hayden, E.P.; Watson, D. Transdiagnostic approaches to psychopathology measurement: Recommendations for measure selection, data analysis, and participant recruitment. J. Abnorm. Psychol. 2020, 129, 21–28. [Google Scholar] [CrossRef] [Scilit]
  78. Barlow, D.H.; Farchione, T.J.; Sauer-Zavala, S.; Murray-Latin, H.; Ellard, K.K.; Bullis, J.R.; Bentley, K.H.; Boettcher, H.T.; Cassiello-Robbins, C. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide, 2nd ed.; Oxford University Press: New York, NY, USA, 2017. [Google Scholar] [CrossRef] [Scilit]
  79. Chorpita, B.F.; Daleiden, E.L.; Weisz, J.R. Modularity in the design and application of therapeutic interventions. Appl. Prev. Psychol. 2005, 11, 141–156. [Google Scholar] [CrossRef] [Scilit]
  80. Wang, Y.; Ma, L.; Wang, J.; Ding, Y.; Liu, N.; Men, W.; Tan, S.; Gao, J.-H.; Qin, S.; He, Y.; et al. The neural and genetic underpinnings of different developmental trajectories of Attention-Deficit/Hyperactivity Symptoms in children and adolescents. BMC Med. 2024, 22, 223. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  81. Achenbach, T.M.; Rescorla, L.A. Manual for the ASEBA Preschool-Age Forms & Profiles; University of Vermont, Research Center for Children, Youth, & Families: Burlington, VT, USA, 2000. [Google Scholar]
  82. Ben-Porath, Y.S.; Tellegen, A. MMPI-3: Manual for Administration, Scoring, and Interpretation; University of Minnesota Press: Minneapolis, MN, USA, 2020. [Google Scholar]
  83. Komasi, S.; Hemmati, A.; Rahmani, K.; Rezaei, F. Construct and Criterion Validity of the HiTOP Spectra to Predict Dimensional and Categorical Somatization in a Large Non-Western Sample. Sci. Rep. 2023, 13, 13197. [Google Scholar] [CrossRef] [Scilit]
  84. Rodriguez-Seijas, C.; Li, J.J.; Balling, C.; Brandes, C.; Bernat, E.; Boness, C.L.; Forbes, M.K.; Forbush, K.T.; Joyner, K.J.; Krueger, R.F.; et al. Diversity and the Hierarchical Taxonomy of Psychopathology (HiTOP). Nat. Rev. Psychol. 2023, 2, 483–495. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.